QNCX — QUINCE THERAPEUTICS INC
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
As of Q2 2026, 31 SEC-registered investment managers reported holding QNCX (QUINCE THERAPEUTICS INC) in their latest 13F filings, with a combined reported value of $22.05M across 590.95K shares. That is -97.4% by share count (-14.13M shares) versus the previous quarter, while reported value moved +366.1%. Ownership is concentrated: the five largest holders account for 84.2% of reported value and the top ten for 96.3%.
Compared with the prior quarter, 12 opened new positions, 3 added to existing stakes, 16 trimmed, 30 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
Major shareholders of QUINCE THERAPEUTICS INC (QNCX) include Capital World Investors, Balyasny Asset Management, Nantahala Capital Management, LLC, ranked by reported 13F value among the 117 institutional holders on this page.
QNCX is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
Institutional Ownership by Quarter
| Quarter | Funds holding | Shares | Value | QoQ Net Change |
|---|---|---|---|---|
| Q3 2026 | 21 | 88.85K | $2.76M | -34.0% |
| Q2 2026 | 31 | 590.95K | $22.05M | -97.4% |
| Q1 2026 | 49 | 21.30M | $2.16M | +150.9% |
| Q4 2025 | 69 | 21.00M | $70.33M | +5.7% |
| Q3 2025 | 47 | 13.05M | $21.27M | +64.5% |
| Q2 2025 | 43 | 7.71M | $12.71M | -6.9% |
| Q1 2025 | 37 | 5.20M | $6.91M | -4.2% |
| Q4 2024 | 38 | 5.11M | $9.56M | +27.3% |
Over the 8 quarters shown, institutional share counts decreased 98% in aggregate (Q4 2024 → Q3 2026); the largest single-quarter swing was Q1 2026 (+150.9%).
Top Institutional Holders (Q3 2026) — 21 funds
Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders
Q2 2026 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 69.97K | $12.56M | 0.04% | New | |
| 115.80K | $2.11M | 0.02% | Reduce | |
| 72.25K | $1.31M | 0.21% | New | |
| 70.78K | $1.29M | 0.00% | Reduce | |
| 70.78K | $1.29M | 0.00% | Reduce | |
| 55.00K | $1.00M | 0.00% | Add | |
| 40.38K | $734.42K | 0.29% | New | |
| 19.30K | $351.07K | 0.00% | Reduce | |
| 17.47K | $329.27K | 0.04% | Reduce | |
| 13.91K | $253.04K | 0.01% | New | |
| 12.64K | $229.96K | 0.00% | New | |
| 12.04K | $219.08K | 0.00% | Reduce | |
| 5.50K | $100.01K | 0.01% | New | |
| 4.73K | $86.04K | 0.00% | Add | |
| 4.08K | $74.29K | 0.00% | Add | |
| 3.61K | $65.74K | 0.00% | Reduce | |
| 1.70K | $30.96K | 0.00% | Reduce | |
| 567 | $10.31K | 0.00% | Reduce | |
| 165 | $3.00K | 0.00% | Reduce | |
| 159 | $2.89K | 0.00% | New | |
| 40 | $728 | 0.00% | Reduce | |
| 27 | $491 | 0.00% | New | |
| 14 | $255 | 0.00% | Reduce | |
| 12 | $218 | 0.00% | New | |
| 10 | $182 | 0.00% | New |
Q1 2026 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 6.27M | $635.70K | 0.01% | Add | |
| 5.20M | $527.28K | 0.00% | Add | |
| 2.50M | $253.88K | 0.00% | Add | |
| 2.50M | $253.88K | 0.00% | Add | |
| 1.77M | $179.77K | 0.03% | New | |
| 600.11K | $60.85K | 0.00% | Reduce | |
| 473.26K | $47.99K | 0.00% | Hold | |
| 461.48K | $46.61K | 0.00% | New | |
| 248.01K | $25.15K | 0.00% | Add | |
| 232.33K | $23.46K | 0.00% | New | |
| 220.00K | $22.31K | 0.00% | New | |
| 132.66K | $13.45K | 0.00% | New | |
| 94.20K | $9.55K | 0.31% | Hold | |
| 71.22K | $7.22K | 0.00% | Reduce | |
| 65.93K | $6.68K | 0.00% | Reduce | |
| 53.31K | $5.41K | 0.00% | Hold | |
| 50.00K | $5.07K | 0.00% | Add | |
| 48.81K | $4.95K | 0.00% | Add | |
| 34.60K | $3.51K | 0.00% | Add | |
| 33.02K | $3.35K | 0.00% | New | |
| 30.00K | $3.04K | 0.00% | New | |
| 20.00K | $2.03K | 0.00% | New | |
| 15.20K | $2.00K | 0.00% | Hold | |
| 19.46K | $1.97K | 0.00% | Reduce | |
| 19.51K | $1.97K | 0.00% | New |
Q4 2025 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 2.67M | $8.95M | 0.45% | Reduce | |
| 2.25M | $7.54M | 0.01% | New | |
| 2.08M | $6.98M | 0.00% | Add | |
| 1.94M | $6.50M | 0.03% | New | |
| 1.19M | $3.99M | 0.00% | Reduce | |
| 1.19M | $3.99M | 0.01% | Reduce | |
| 979.27K | $3.28M | 0.01% | Hold | |
| 930.13K | $3.12M | 0.69% | Add | |
| 858.71K | $2.88M | 1.54% | New | |
| 739.26K | $2.48M | 0.48% | New | |
| 538.10K | $1.80M | 0.00% | Add | |
| 523.90K | $1.76M | 0.00% | Add | |
| 521.07K | $1.75M | 0.00% | Add | |
| 511.86K | $1.71M | 0.00% | Add | |
| 471.99K | $1.58M | 0.00% | Add | |
| 345.10K | $1.16M | 0.00% | New | |
| 328.50K | $1.10M | 0.00% | Add | |
| 238.18K | $797.89K | 0.04% | New | |
| 230.61K | $772.55K | 0.00% | Add | |
| 229.69K | $769.48K | 0.00% | New | |
| 224.75K | $752.90K | 0.40% | Hold | |
| 189.79K | $635.79K | 0.00% | New | |
| 189.12K | $633.56K | 0.03% | Hold | |
| 180.95K | $606.18K | 0.00% | Add | |
| 112.03K | $375.00K | 0.03% | Add |
Q3 2025 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 3.07M | $5.01M | 0.20% | Add | |
| 1.76M | $2.87M | 0.00% | Add | |
| 1.39M | $2.26M | 0.00% | Add | |
| 1.39M | $2.26M | 0.00% | Add | |
| 981.26K | $1.60M | 0.01% | Add | |
| 775.03K | $1.26M | 0.13% | Add | |
| 494.78K | $806.49K | 0.18% | New | |
| 468.60K | $763.82K | 0.00% | Add | |
| 437.29K | $712.91K | 0.00% | Add | |
| 345.46K | $563.10K | 0.00% | Add | |
| 308.50K | $502.86K | 0.00% | Hold | |
| 224.75K | $366.34K | 0.15% | Add | |
| 210.04K | $342.37K | 0.00% | New | |
| 198.11K | $322.92K | 0.00% | Add | |
| 189.12K | $308.27K | 0.01% | Hold | |
| 136.96K | $223.24K | 0.04% | Reduce | |
| 122.46K | $199.61K | 0.00% | Hold | |
| 95.12K | $155.05K | 0.00% | Reduce | |
| 91.06K | $148.43K | 0.00% | Hold | |
| 87.23K | $142.00K | 0.01% | Add | |
| 64.71K | $105.47K | 0.00% | Reduce | |
| 35.16K | $57.31K | 0.00% | New | |
| 31.57K | $51.45K | 0.01% | New | |
| 30.23K | $49.27K | 0.01% | Hold | |
| 16.20K | $26.00K | 0.00% | New |
Q2 2025 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 2.53M | $4.17M | 0.18% | New | |
| 1.45M | $2.40M | 0.00% | Add | |
| 439.27K | $724.80K | 0.01% | Reduce | |
| 396.98K | $655.15K | 0.00% | Hold | |
| 379.80K | $626.67K | 0.00% | Reduce | |
| 335.74K | $553.97K | 0.00% | Reduce | |
| 308.50K | $509.02K | 0.00% | Reduce | |
| 189.12K | $312.05K | 0.01% | Hold | |
| 169.55K | $279.76K | 0.00% | New | |
| 150.00K | $247.50K | 0.05% | Reduce | |
| 142.96K | $235.88K | 0.04% | Hold | |
| 128.62K | $212.22K | 0.01% | Add | |
| 124.91K | $206.10K | 0.00% | Hold | |
| 122.46K | $202.06K | 0.00% | Hold | |
| 120.86K | $199.41K | 0.09% | New | |
| 110.68K | $182.62K | 0.00% | New | |
| 110.68K | $182.62K | 0.00% | New | |
| 93.91K | $154.94K | 0.00% | Add | |
| 91.06K | $150.25K | 0.00% | Hold | |
| 77.49K | $127.86K | 0.00% | Hold | |
| 53.31K | $87.97K | 0.02% | Hold | |
| 33.82K | $56.00K | 0.00% | Reduce | |
| 30.23K | $49.88K | 0.02% | Hold | |
| 22.66K | $37.39K | 0.00% | New | |
| 17.39K | $28.69K | 0.00% | Reduce |
New Positions (Q2 2026)
- Balyasny Asset Management 69.97K sh · $12.56M
- Ikarian Capital, LLC 72.25K sh · $1.31M
- Squadron Capital Management LLC 40.38K sh · $734.42K
- BOOTHBAY FUND MANAGEMENT, LLC 13.91K sh · $253.04K
- JANE STREET GROUP, LLC 12.64K sh · $229.96K
- Cormorant Asset Management, LP 5.50K sh · $100.01K
- Operose Advisors LLC 159 sh · $2.89K
- BARCLAYS PLC 27 sh · $491
- Integrated Wealth Concepts LLC 12 sh · $218
- Wells Fargo & Co 10 sh · $182
- Allworth Financial LP 8 sh · $137
- Steward Partners Investment Advisory, LLC 1 sh · $18
Fully Exited (vs previous quarter)
- Woodline Partners LP sold 5.20M sh · $527.28K
- IEQ CAPITAL, LLC sold 600.11K sh · $60.85K
- STATE STREET CORP sold 248.01K sh · $25.15K
- Vanguard Personalized Indexing Management, LLC sold 132.66K sh · $13.45K
- Eiger Wealth Management, LLC sold 94.20K sh · $9.55K
- Two Sigma Investments sold 71.22K sh · $7.22K
- Northern Trust Corp sold 65.93K sh · $6.68K
- Intellectus Partners, LLC sold 53.31K sh · $5.41K
- ADAR1 Capital Management, LLC sold 50.00K sh · $5.07K
- XTX Topco Ltd sold 48.81K sh · $4.95K
- Citadel Advisors sold 34.60K sh · $3.51K
- Catalyst Funds Management Pty Ltd sold 30.00K sh · $3.04K
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Birchview Capital, LP | 40.60K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| JANE STREET GROUP, LLC | 20.16K | 12.64K | — | 521.07K | 35.16K | — | — | 10.47K | — | — | — | 119.74K | 75.89K | — | — | — | — | — | — | — |
| Geode Capital Management | 9.74K | — | — | 523.90K | 437.29K | 396.98K | 395.71K | 375.93K | 339.12K | 272.95K | 266.90K | 261.74K | 219.60K | 187.16K | 137.09K | 137.09K | 146.21K | 146.21K | 283.11K | 309.60K |
| VANGUARD CAPITAL MANAGEMENT LLC | 9.22K | 12.04K | 461.48K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| VANGUARD FIDUCIARY TRUST CO | 5.37K | 3.61K | 232.33K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| BlackRock Inc | 1.69K | 1.70K | 473.26K | 471.99K | 345.46K | 335.74K | 345.45K | 447.73K | 358.36K | — | — | — | — | — | — | — | — | — | — | — |
| JPMorgan Chase & Co | 792 | 2 | 469 | 469 | 469 | 469 | 547 | 545 | 548 | 469 | 469 | 469 | 469 | 126.77K | 469 | — | 291.07K | 602.05K | 590.42K | 10.10K |
| Morgan Stanley | 794 | 4.08K | 834 | 10.62K | 3.69K | 4.30K | 53.57K | 76.70K | 8.52K | 8.52K | 8.40K | 9.09K | 9.54K | 7.25K | 9.69K | 11.76K | 226.65K | 534.73K | 809.35K | 1.03M |
| GROUP ONE TRADING LLC | 234 | 19.30K | 6.27M | 13.80K | 10.00K | 16.20K | 246 | 37.70K | — | 1.60K | 1.61K | — | 46.00K | — | — | — | — | — | — | — |
| Gen-Wealth Partners Inc | 166 | 165 | 33.02K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Fortitude Family Office, LLC | 41 | 40 | 8.10K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| BFC Planning, Inc. | 15 | 14 | 2.97K | 2.97K | 2.97K | — | 2.97K | 2.97K | 2.97K | — | — | — | — | — | — | — | — | — | — | — |
| BNP PARIBAS FINANCIAL MARKETS | 9 | — | 8 | 8 | 8 | 8 | — | — | — | 24 | 24 | 24 | 59 | — | — | — | — | — | — | — |
| Parallel Advisors, LLC | 6 | 3 | 795 | 295 | 295 | 295 | 295 | 295 | 295 | 295 | 311 | 2.38K | 2.38K | — | — | — | — | — | — | — |
| Allworth Financial LP | 8 | 8 | — | 1.50K | — | — | — | — | — | — | — | — | 267 | — | — | — | — | — | — | — |
| UBS Group AG | 4 | 4.73K | 556 | 35.09K | 1.47K | 2.85K | 706 | 1.11K | 480 | 480 | 505 | 505 | 6.67K | 912 | 325 | 45.87K | 33.30K | 25.12K | 25.59K | 15.65K |
| OSAIC HOLDINGS, INC. | 2 | — | 550 | 827 | 827 | 277 | 277 | 782 | 277 | 277 | 277 | 277 | 277 | — | — | — | — | — | — | — |
| Fidelity Management & Research (FMR) | 1 | — | — | 70 | — | — | 50 | — | — | — | 1.50K | — | — | — | — | — | — | 379 | 818 | — |
| JONES FINANCIAL COMPANIES LLLP | 1 | — | 133 | 133 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Westside Investment Management, Inc. | 1 | 1 | 75 | 75 | 75 | 75 | 75 | 75 | 75 | 75 | 75 | 75 | 75 | — | — | — | — | — | — | — |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details
FAQ
Which funds hold QNCX?
As of 2026-Q2, 31 institutional funds reported holding QNCX (QUINCE THERAPEUTICS INC) in SEC 13F filings, with a combined reported value of $22.05M.
How many shares of QNCX do institutions own?
13F filers reported 590.95K shares of QNCX, worth $22.05M in aggregate at the end of 2026-Q2.
Is institutional ownership of QNCX rising or falling?
Share counts moved -97.4% versus the prior quarter — distribution.
Who are the top institutional holders of QNCX?
The largest 13F holders are Capital World Investors, Balyasny Asset Management, Nantahala Capital Management, LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., Vanguard Group; the top 25 are ranked at the top of this page.
Who are the major shareholders of QUINCE THERAPEUTICS INC?
The major shareholders of QUINCE THERAPEUTICS INC (QNCX) by reported 13F value are Capital World Investors, Balyasny Asset Management, Nantahala Capital Management, LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., Vanguard Group, among 117 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.